Tick vaccines: Current status and future directions

Expert Review of Vaccines

Volumn 14, Issue 10, 2015, Pages 1367-1376

  De La Fuente, José ^a,b   Contreras, Marinela ^a  

^a INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

acaricide; control; tick; vaccine; vaccinomics

Indexed keywords

TICK VACCINE; UNCLASSIFIED DRUG; VACCINE; ANTIGEN;

ALGORITHM; CONTROL STRATEGY; DISEASE TRANSMISSION; DRUG SCREENING; ECTOPARASITE; INFECTION CONTROL; INSECT CONTROL; PRIORITY JOURNAL; REVIEW; TICK BORNE DISEASE; ANIMAL; HUMAN; IMMUNOLOGY; PROCEDURES; TICK; TICK INFESTATIONS; TICK-BORNE DISEASES; TRANSMISSION;

ANIMALS; ANTIGENS; HUMANS; TICK CONTROL; TICK INFESTATIONS; TICK-BORNE DISEASES; TICKS; VACCINES;

EID: 84941804078     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2015.1076339     Document Type: Review

References (118)

1. Camicas JL, Hervy JP, Adam F, Morel PC. The ticks of the world (Acarida, Ixodida). Orstom editions; Paris, France: 1998
2. de la Fuente J, Estrada-Penã A, Venzal JM, et al. Overview: Ticks as vectors of pathogens that cause disease in humans and animals. Front Biosc 2008; 13: 6938-46
3. Gortazar C, Reperant LA, Kuiken T, et al. Crossing the interspecies barrier: opening the door to zoonotic pathogens. PLoS Pathog 2014; 10: e1004129
4. Otranto D, Cantacessi C, Pfeffer M, et al. The role of wild canids and felids in spreading parasites to dogs and cats in Europe: Part I: Protozoa and tick-borne agents. Vet Parasitol 2015; in press
5. Estrada-Penã A, Ayllón N, de la Fuente J. Impact of climate trends on tick-borne pathogen transmission. Front Physiol 2012; 3: 64
6. Estrada-Penã A, Ostfeld RS, Peterson AT, et al. Effects of environmental change on zoonotic disease risk: an ecological primer. Trends Parasitol 2014; 30: 205-14
7. Estrada-Penã A, de la Fuente J, Latapia T, Ortega C. The impact of climate trends on a tick affecting public health: A retrospective modeling approach for Hyalomma marginatum (Ixodidae). PLoS One 2015; 10: e0125760
8. Ostfeld RS, Brunner JL. Climate change and Ixodes tick-borne diseases of humans. Philos Trans R Soc Lond B Biol Sci 2015; 370: 20140051
9. Juckett G. Arthropod bites. Am Fam Physician 2013; 88: 841-7
10. de la Fuente J, Kocan KM. Development of Vaccines for Control of Tick Infestations and Interruption of Pathogen Transmission. In: Biology of Ticks. 2nd Edition. Sonenshine D, Roe M.,. Eds Oxford University Press; Newyork: 2014. pp 333-52
11. de la Fuente J, Kocan KM. Advances in the identification and characterization of protective antigens for development of recombinant vaccines against tick infestations. Exp Rev Vaccines 2003; 2: 583-93
12. de la Fuente J, Kocan KM. Strategies for development of vaccines for control of ixodid tick species. Parasite Immunol 2006; 28: 275-83
13. Willadsen P. Tick control: thoughts on a research agenda. Vet Parasitol 2006; 138: 161-8
14. Sonenshine DE, Kocan KM, de la Fuente J. Tick control: further thoughts on a research agenda. Trends Parasitol 2006; 22: 550-1
15. de la Fuente J, Almazán C, Canales M, et al. A ten-year review of commercial vaccine performance for control of tick infestations on cattle. Ann Health Res Rev 2007; 8: 23-8
16. Hai VV, Almeras L, Socolovschi C, et al. Monitoring human tick-borne disease risk and tick bite exposure in Europe: available tools and promising future methods. Ticks Tick Borne Dis 2014; 5: 607-19
17. Graf JF, Gogolewski R, Leach-Bing N, et al. Tick control: an industry point of view. Parasitol 2004; 129: S427-42
18. Willadsen P, McKenna RV, Riding GA. Isolation from the cattle tick, Boophilus microplus, of antigenic material capable of eliciting a protective immunological response in the bovine host. Int J Parasitol 1988; 18: 183-9
19. Willadsen P, Riding GA, McKenna RV, et al. Immunological control of a parasitic arthropod: identification of a protective antigen from Boophilus microplus. J Immunol 1989; 143: 1346-51
20. Willadsen P. Vaccination against ectoparasites. Parasitol 2006; 133 Suppl: S9-25
21. Willadsen P, Kemp DH. Vaccination with concealed antigens for tick control. Parasitol Today 1988; 4: 196-8
22. Rand KN, Moore T, Sriskantha A, et al. Cloning and expression of a protective antigen from the cattle tick Boophilus microplus. Proc Natl Acad Sci USA 1989; 86: 9657-61
23. Guerrero FD, Miller RJ, Pérez de León AA. Cattle tick vaccines: many candidate antigens, but will a commercially viable product emerge? Int J Parasitol 2012; 42: 421-7
24. Kiss T, Cadar D, Spînu M. Tick prevention at a crossroad: new and renewed solutions. Vet Parasitol 2012; 187: 357-66
25. Parizi LF, Githaka NW, Logullo C, et al. The quest for a universal vaccine against ticks: cross-immunity insights. Vet J 2012; 194: 158-65
26. de la Fuente J, Merino O. Vaccinomics, the new road to tick vaccines. Vaccine 2013; 31: 5923-9
27. Diáz-Martín V, Manzano-Román R, Obolo-Mvoulouga P, et al. Development of vaccines against Ornithodoros soft ticks: An update. Ticks Tick Borne Dis 2015; 6: 211-20
28. Neelakanta G, Sultana H. Transmission-blocking vaccines: Focus on anti-vector vaccines against tick-borne diseases. Arch Immunol Ther Exp (Warsz) 2015; 63: 169-79
29. Rosario-Cruz R, Almazan C, Miller RJ, et al. Genetic basis and impact of tick acaricide resistance. Front Biosci 2009; 14: 2657-65
30. Abbas RZ, Zaman MA, Colwell DD, et al. Acaricide resistance in cattle ticks and approaches to its management: the state of play. Vet Parasitol 2014; 203: 6-20
31. Pérez de León AA, Teel PD, Auclair AN, et al. Integrated strategy for sustainable cattle fever tick eradication in USA is required to mitigate the impact of global change. Front Physiol 2012; 3: 195
32. Fernandes ÉK, Bittencourt VR, Roberts DW. Perspectives on the potential of entomopathogenic fungi in biological control of ticks. Exp Parasitol 2012; 130: 300-5
33. Shyma KP, Gupta JP, Singh V. Breeding strategies for tick resistance in tropical cattle: a sustainable approach for tick control. J Parasit Dis 2015; 39: 1-6
34. Mapholi NO, Marufu MC, Maiwashe A, et al. Towards a genomics approach to tick (Acari: Ixodidae) control in cattle: a review. Ticks Tick Borne Dis 2014; 5: 475-83
35. Elvin CM, Kemp DH. Generic approaches to obtaining efficacious antigens from vector arthropods. Int J Parasitol 1994; 24: 67-79
36. de la Fuente J. Vaccines for vector control: Exciting possibilities for the future. Vet J 2012; 194: 139-40
37. Merino O, Almazán C, Canales M, et al. Control of Rhipicephalus (Boophilus) microplus infestations by the combination of subolesin vaccination and tick autocidal control after subolesin gene knockdown in ticks fed on cattle. Vaccine 2011; 29: 2248-54
38. Estrada-Penã A, de la Fuente J, Ostfeld RS, Cabezas-Cruz A. Interactions between tick and transmitted pathogens evolved to minimise competition through nested and coherent networks. Sci Rep 2015; 5: 10361
39. Rodríguez-Valle M, Taoufik A, Valdés M, et al. Efficacy of Rhipicephalus (Boophilus) microplus Bm86 against Hyalomma dromedarii and Amblyomma cajennense tick infestations in camels and cattle. Vaccine 2012; 30: 3453-8
40. Carreón D, Pérez de la Lastra JM, Almazán C, et al. Vaccination with BM86, subolesin and akirin protective antigens for the control of tick infestations in white tailed deer and red deer. Vaccine 2012; 30: 273-9
41. Moreno-Cid JA, Pérez de la Lastra JM, Villar M, et al. Control of multiple arthropod vector infestations with subolesin/akirin vaccines. Vaccine 2013; 31: 1187-96
42. de la Fuente J, Moreno-Cid JA, Canales M, et al. Targeting arthropod subolesin/akirin for the development of a universal vaccine for control of vector infestations and pathogen transmission. Vet Parasitol 2011; 181: 17-22
43. de la Fuente J, Moreno-Cid JA, Galindo RC, et al. Subolesin/Akirin vaccines for the control of arthropod vectors and vector-borne pathogens. Transbound Emerg Dis 2013; 60 (Suppl 2): 172-8
44. de la Fuente J, Villar M, Contreras M, et al. Prospects for vaccination against the ticks of pets and the potential impact on pathogen transmission. Vet Parasitol 2015; 208: 26-9
45. Torina A, Moreno-Cid JA, Blanda V, et al. Control of tick infestations and pathogen prevalence in cattle and sheep farms vaccinated with the recombinant Subolesin-Major Surface Protein 1a chimeric antigen. Parasit Vectors 2014; 7: 10
46. Canales M, Naranjo V, Almazán C, et al. Conservation and immunogenicity of the mosquito ortholog of the tick protective antigen. subolesin. Parasitol Res 2009; 105: 97-111
47. Canales M, Almazán C, Naranjo V, et al. Vaccination with recombinant Boophilus annulatus Bm86 ortholog protein, Ba86, protects cattle against B. annulatus and B. microplus infestations. BMC Biotechnol 2009; 9: 29
48. Galaï Y, Ben Saïd M, Jedidi M, et al. Efficacy of Hyalomma scupense (Hd86) antigen against Hyalomma excavatum and H. scupense tick infestations in cattle. Vaccine 2012; 30: 7084-9
49. Kumar B, Azhahianambi P, Ray DD, et al. 2012; Comparative efficacy of rHaa86 and rBm86 against Hyalomma anatolicum anatolicum and Rhipicephalus (Boophilus) microplus. Parasite Immunol 34: 297-301
50. Almazán C, Kocan KM, Bergman DK, et al. Identification of protective antigens for the control of Ixodes scapularis infestations using cDNA expression library immunization. Vaccine 2003; 21: 1492-501
51. Allen JR, Humphreys SJ. Immunization of guinea pigs and cattle against ticks. Nature 1979; 280: 491-3
52. Merino M, Antunes S, Mosqueda J, et al. Vaccination with proteins involved in tick-pathogen interactions reduces vector infestations and pathogen infection. Vaccine 2013; 31: 5889-96
53. Schetters TPM, Jansen T. Vaccine against Rhipicephalus ticks. International application number: PCT/EP2014/056248. International publication number: WO 2014/154847 A1. Available from: www.google.com/patents/WO2014154847A1?cl=en
54. Merino O, Alberdi P, Pérez de la Lastra JM, de la Fuente J. Tick vaccines and the control of tick-borne pathogens. Front Cell Infect Microbiol 2013; 3: 30
55. Naranjo N, Ayllón N, Pérez de la Lastra JM, et al. Reciprocal regulation of NF-kB (Relish) and Subolesin in the tick vector, Ixodes scapularis. PLoS One 2013; 8: e65915
56. Hajdusek O, Šíma R, Ayllón N, et al. Interaction of the tick immune system with transmitted pathogens. Front Cell Infect Microbiol 2013; 3: 26
57. de la Fuente J, Blouin EF, Manzano-Roman R, et al. Functional genomic studies of tick cells in response to infection with the cattle pathogen, Anaplasma marginale. Genomics 2007; 90: 712-22
58. Kocan KM, de la Fuente J, Blouin EF. Advances toward understanding the molecular biology of the Anaplasma-tick interface. Front Biosci 2008; 13: 7032-45
59. Zivkovic Z, Esteves E, Almazán C, et al. Differential expression of genes in salivary glands of male Rhipicephalus (Boophilus) microplus in response to infection with Anaplasma marginale. BMC Genomics 2010; 11: 186
60. Merino O, Almazán C, Canales M, et al. Targeting the tick protective antigen subolesin reduces vector infestations and pathogen infection by Anaplasma marginale and Babesia bigemina. Vaccine 2011; 29: 8575-9
61. Villar M, Popara M, Bonzón-Kulichenko E, et al. Characterization of the tick-pathogen interface by quantitative proteomics. Ticks Tick Borne Dis 2012; 3: 154-8
62. Liu XY, de la Fuente J, Cote M, et al. IrSP1, a tick serine protease inhibitor involved in tick feeding and Bartonella henselae infection. PLoS Negl Trop Dis 2014; 8: e2993
63. Antunes S, Galindo RC, Almazán C, et al. Functional genomics studies of Rhipicephalus (Boophilus) annulatus ticks in response to infection with the cattle protozoan parasite, Babesia bigemina. Int J Parasitol 2012; 42: 187-95
64. Antunes S, Merino O, Mosqueda J, et al. Tick capillary feeding for the study of proteins involved in tick-pathogen interactions as potential antigens for the control of tick infestation and pathogen infection. Parasit Vectors 2014; 7: 42
65. Hammac GK, Pierlé SA, Cheng X, et al. Global transcriptional analysis reveals surface remodeling of Anaplasma marginale in the tick vector. Parasit Vectors 2014; 7: 193
66. Ayllón N, Villar V, Galindo RC, et al. Systems biology of tissue-specific response to Anaplasma phagocytophilum reveals differentiated apoptosis in the tick vector Ixodes scapularis. PLoS Genet 2015; 11: e1005120
67. Gomes-Solecki M. Blocking pathogen transmission at the source: reservoir targeted OspA-based vaccines against Borrelia burgdorferi. Front Cell Infect Microbiol 2014; 4: 136
68. Ishikawa T, Yamanaka A, Konishi E. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available. Vaccine 2014; 32: 1326-37
69. Lin M, Kikuchi T, Brewer HM, et al. Global proteomic analysis of two tick-borne emerging zoonotic agents: Anaplasma phagocytophilum and Ehrlichia chaffeensis. Front Microbiol 2011; 2: 24
70. Ge Y, Rikihisa Y. Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics. J Bacteriol 2007; 189: 7819-28
71. Mastronunzio JE, Kurscheid S, Fikrig E. Postgenomic analyses reveal development of infectious Anaplasma phagocytophilum during transmission from ticks to mice. J Bacteriol 2012; 194: 2238-47
72. de la Fuente J, Garciá-Garciá JC, Blouin EF, Kocan KM. Differential adhesion of major surface proteins 1a and 1b of the ehrlichial cattle pathogen Anaplasma marginale to bovine erythrocytes and tick cells. Int J Parasitol 2001; 31: 145-53
73. Brayton KA, Palmer GH, Brown WC. Genomic and proteomic approaches to vaccine candidate identification for Anaplasma marginale. Expert Rev Vaccines 2006; 5: 95-101
74. Noh SM, Brayton KA, Brown WC, et al. Composition of the surface proteome of Anaplasma marginale and its role in protective immunity induced by outer membrane immunization. Infect Immun 2008; 76: 2219-26
75. Ramabu SS, Ueti MW, Brayton KA, et al. Identification of Anaplasma marginale proteins specifically upregulated during colonization of the tick vector. Infect Immun 2010; 78: 3047-52
76. Palmer GH, Brown WC, Noh SM, Brayton KA. Genome-wide screening and identification of antigens for rickettsial vaccine development. FEMS Immunol Med Microbiol 2012; 64: 115-19
77. Nuñez PA, Moretta R, Ruybal P, et al. Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale. Curr Microbiol 2014; 68: 269-77
78. Cabezas-Cruz A, de la Fuente J. Anaplasma marginale major surface protein 1a: A marker of strain diversity with implications for control of bovine anaplasmosis. Ticks Tick-Borne Dis 2015; 6: 205-10
79. Canales M, Almazán C, Pérez de la Lastra JM, de la Fuente J. Anaplasma marginale major surface protein 1a directs cell surface display of tick BM95 immunogenic peptides on Escherichia coli. J Biotechnol 2008; 135: 326-32
80. Canales M, Labruna MB, Soares JF, et al. Protective efficacy of bacterial membranes containing surface-exposed BM95 antigenic peptides for the control of cattle tick infestations. Vaccine 2009; 27: 7244-8
81. Almazán C, Moreno-Cantú O, Moreno-Cid JA, et al. Control of tick infestations in cattle vaccinated with bacterial membranes containing surface-exposed tick protective antigens. Vaccine 2012; 30: 265-72
82. Jones KE, Patel NG, Levy MA, et al. Global trends in emerging infectious diseases. Nature 2008; 451: 990-4
83. Peter RJ, Van den Bossche P, Penzhorn BL, Sharp B. Tick, fly, and mosquito control-lessons from the past, solutions for the future. Vet Parasitol 2005; 132: 205-15
84. Hopla CE, Durden LA, Keirans JE. Ectoparasites and classification. Rev sci tech Off int Epiz 1994; 13: 985-1017
85. Torres L, Almazán C, Ayllón N, et al. Functional genomics of the horn fly, Haematobia irritans (Linnaeus, 1758). BMC Genomics 2011; 12: 105
86. Marr EJ, Sargison ND, Nisbet AJ, Burgess ST. RNA interference for the identification of ectoparasite vaccine candidates. Parasite Immunol 2014; 36: 616-26
87. Sparagano OA, George DR, Harrington DW, Giangaspero A. Significance and control of the poultry red mite, Dermanyssus gallinae. Annu Rev Entomol 2014; 59: 447-66
88. McNair CM. Ectoparasites of medical and veterinary importance: drug resistance and the need for alternative control methods. J Pharm Pharmacol 2015; 67: 351-63
89. da Costa M, Pinheiro-Silva R, Antunes S, et al. Mosquito Akirin as a potential antigen for malaria control. Malaria J 2014; 13: 240
90. Marcelino I, de Almeida AM, Ventosa M, et al. Tick-borne diseases in cattle: applications of proteomics to develop new generation vaccines. J Proteomics 2012; 75: 4232-50
91. Maritz-Olivier C, van Zyl W, Stutzer C. A systematic, functional genomics, and reverse vaccinology approach to the identification of vaccine candidates in the cattle tick, Rhipicephalus microplus. Ticks Tick Borne Dis 2012; 3: 179-87
92. Kemp DH, Pearson RD, Gough JM, Willadsen P. Vaccination against B. microplus: localisation of antigens on ticks gut cells and their interaction with the host immune system. Exp Appl Acarol 1989; 7: 43-58
93. Ribeiro JM, Francischetti IM. Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives. Ann Rev Entomol 2003; 48: 73-88
94. Trimnell AR, Davies GM, Lissina O, et al. A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine. Vaccine 2005; 23: 4329-41
95. Xu Y, Bruno JF, Luft BJ. Identification of novel tick salivary gland proteins for vaccine development. Biochem Biophys Res Commun 2005; 326: 901-4
96. Havlíková S, Roller L, Koci J, et al. Functional role of 64P, the candidate transmission-blocking vaccine antigen from the tick, Rhipicephalus appendiculatus. Int J Parasitol 2009; 39: 1485-94
97. Kopácek P, Hajdusek O, Buresová V, Daffre S. Tick innate immunity. Adv Exp Med Biol 2010; 708: 137-62
98. Kongsuwan K, Josh P, Zhu Y, et al. Exploring the midgut proteome of partially fed female cattle tick (Rhipicephalus (Boophilus) microplus). J Insect Physiol 2010; 56: 212-26
99. Sonenshine DE, Bissinger BW, Egekwu N, et al. First transcriptome of the testis-vas deferens-male accessory gland and proteome of the spermatophore from Dermacentor variabilis (Acari: Ixodidae). PLoS One 2011; 6: e24711
100. Seixas A, Oliveira P, Termignoni C, et al. Rhipicephalus (Boophilus) microplus embryo proteins as target for tick vaccine. Vet Immunol Immunopathol 2012; 148: 149-56
101. Hajdusek O, Sojka D, Kopacek P, et al. Knockdown of proteins involved in iron metabolism limits tick reproduction and development. Proc Natl Acad Sci USA 2009; 106: 1033-8
102. Hajdusek O, Almazán C, Loosova G, et al. Characterization of ferritin 2 for the control of tick infestations. Vaccine 2010; 28: 2993-8
103. Sojka D, Franta Z, Horn M, et al. New insights into the machinery of blood digestion by ticks. Trends Parasitol 2013; 29: 276-85
104. Mulenga A, Kim TK, Ibelli AM. Deorphanization and target validation of cross-tick species conserved novel Amblyomma americanum tick saliva protein. Int J Parasitol 2013; 43: 439-51
105. Popara M, Villar M, Mateos-Hernández L, et al. Lesser protein degradation machinery correlates with higher BM86 tick vaccine efficacy in Rhipicephalus annulatus when compared to R. microplus. Vaccine 2013; 31: 4728-35
106. Trimnell AR, Hails RS, Nuttall PA. Dual action ectoparasite vaccine targeting "exposed" and "concealed" antigens. Vaccine 2002; 20: 3560-8
107. Nuttall PA, Trimnell AR, Kazimirova M, Labuda M. Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases. Parasite Immunol 2006; 28: 155-63
108. Estrada-Penã A, Carreón D, Almazán C, de la Fuente J. Modeling the impact of climate and landscape on the efficacy of white tailed deer vaccination for cattle tick control in northeastern Mexico. PLoS One 2014; 9: e102905
109. Favia G. Engineered mosquitoes to fight mosquito borne diseases: not a merely technical issue. Bioengineered 2015; 6: 5-7
110. Santamaria ME, Cambra I, Martinez M, et al. Gene pyramiding of peptidase inhibitors enhances plant resistance to the spider mite Tetranychus urticae. PLoS ONE 2012; 7: e43011
111. de la Fuente J, Canales M, Kocan KM. The importance of protein glycosylation in development of novel tick vaccine strategies. Parasite Immunol 2006; 28: 687-8
112. Narasimhan S, Fikrig E. Tick microbiome: the force within. Trends Parasitol 2015; in press
113. Canales M, Enriiquez A, Ramos E, et al. Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick. Vaccine 1997; 15: 414-22
114. Aguirre Ade A, Garcia MV, Szabó MP, et al. Formula to evaluate efficacy of vaccines and systemic substances against three-host ticks. Int J Parasitol 2015; 45: 357-9
115. Ali A, Parizi LF, Garcia Guizzo MG, et al. Immunoprotective potential of a Rhipicephalus (Boophilus) microplus metalloprotease. Vet Parasitol 2015; 207: 107-14
116. Rodríguez-Mallon A, Encinosa PE, Méndez-Pérez L, et al. High efficacy of a 20 amino acid peptide of the acidic ribosomal protein P0 against the cattle tick, Rhipicephalus microplus. Ticks Tick Borne Dis 2015; 6: 530-7
117. Guerrero FD, Andreotti R, Bendele KG, et al. Rhipicephalus (Boophilus) microplus aquaporin as an effective vaccine antigen to protect against cattle tick infestations. Parasit Vectors 2014; 7: 475
118. Shakya M, Kumar B, Nagar G, et al. Subolesin: A candidate vaccine antigen for the control of cattle tick infestations in Indian situation. Vaccine 2014; 32: 3488-94